Orion Biotech Opportunities Corp. (ORIA)
| Market Cap | 244.25M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 25.00M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 26 |
| Last Price | $9.77 |
| Previous Close | $9.70 |
| Change ($) | 0.07 |
| Change (%) | 0.72% |
| Day's Open | - |
| Day's Range | 9.45 - 9.90 |
| Day's Volume | 92 |
| 52-Week Range | 9.45 - 10.00 |
NEW YORK, July 1, 2021 /PRNewswire/ -- Orion Biotech Opportunities Corp. (Nasdaq: ORIAU) (the "Company" or "us") announced that, commencing July 2, 2021, holders of the units sold in the Company's init...
NEW YORK, May 12, 2021 /PRNewswire/ -- Orion Biotech Opportunities Corp. (the "Company") today announced the pricing of its initial public offering ("IPO") of 20,000,000 units at a price of $10.00 per u...
Orion Biotech Opportunities, a blank check company formed by MSD Partners and Panacea Venture targeting the biotech and life science sectors, filed on Thursday with the SEC to raise up to $200 million i...
Orion Biotech Opportunities Corp. has filed to go public with an IPO on the NASDAQ.
About ORIA
Orion Biotech Opportunities is a newly incorporated blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to focus on the biotechnology and life sciences industries. In particular, we will target North American, European, and Asian healthcare companies with the potential to drive transformational change through the development and commercialization of nove... [Read more...]
| Industry Blank Checks / SPAC | IPO Date May 13, 2021 |
| CEO James Huang | Country United States |
| Stock Exchange NASDAQ | Ticker Symbol ORIA |